The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 2, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2019

Conditions
Hypnotic Dependence Among Those With Insomnia
Interventions
DRUG

0% Hypnotic Medication Taper

Participants will not have their soporific hypnotic medication dosage changed during a 20 week blinded tapering period

DRUG

25% Hypnotic Medication Taper

Participants will have their soporific hypnotic medication dosage reduced by 25% every two weeks during a 20 week blinded tapering period.

DRUG

10% Hypnotic Medication Taper

Participants will have their soporific hypnotic medication dosage reduced by 10% every two weeks during a 20 week blinded tapering period.

Trial Locations (1)

80206'

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER

NCT02831894 - The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation | Biotech Hunter | Biotech Hunter